Company intelligence / Profile preview

Apnar Pharma

Chino, California, United Statesapnarpharma.com ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Apnar Pharma develops, manufactures, markets, and distributes generic pharmaceuticals and over-the-counter non-prescription items for the U.S. market. The company has expanded through acquisition of FDA-approved manufacturing capabilities. No clinical trial results reported as it focuses on generics.

Modalities: Small molecule
Industry: Biotech

Partnerships

Engages in strategic partnerships for product development/licensing/distribution but no major pharma partners named publicly

Beyond the preview

Go deeper on Apnar Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apnar Pharma.

Explore the full profile